The effect of a Japanese traditional medicine, hachimijiogan (kampo), on regulatory CD4+CD25+T cells in Mikulicz's disease.
Tsuda
Tokutaro
T
Department of Oriental Medicine, Kitasato University Graduate School, Kanagawa, Japan. tsuda-t@insti.kitasato-u.ac.jp
Kobayashi
Kazuhiko
K
Seki
Kunihiko
K
Yashiro
Shinobu
S
Ino
Takeshi
T
Kato
Kohei
K
Hanawa
Toshihiko
T
D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects*; D004359:Drug Therapy, Combination; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D053645:Interleukin-2 Receptor alpha Subunit; D020835:Medicine, Kampo; D008875:Middle Aged; D008882:Mikulicz' Disease / Q000188:drug therapy* / Q000276:immunology; D008517:Phytotherapy; D011239:Prednisolone / Q000627:therapeutic use
D004365:Drugs, Chinese Herbal; D005938:Glucocorticoids; C508017:IL2RA protein, human; D053645:Interleukin-2 Receptor alpha Subunit; C054591:hachimijiogan; D011239:Prednisolone